171 related articles for article (PubMed ID: 22634237)
1. Development of a novel probe sonication assisted enhanced loading of 5-FU in SPION encapsulated pectin nanocarriers for magnetic targeted drug delivery system.
Dutta RK; Sahu S
Eur J Pharm Biopharm; 2012 Sep; 82(1):58-65. PubMed ID: 22634237
[TBL] [Abstract][Full Text] [Related]
2. Pectin/Ethylcellulose as film coatings for colon-specific drug delivery: preparation and in vitro evaluation using 5-fluorouracil pellets.
Wei H; Qing D; De-Ying C; Bai X; Fanli-Fang
PDA J Pharm Sci Technol; 2007; 61(2):121-30. PubMed ID: 17479720
[TBL] [Abstract][Full Text] [Related]
3. Development of oxaliplatin encapsulated in magnetic nanocarriers of pectin as a potential targeted drug delivery for cancer therapy.
Dutta RK; Sahu S
Results Pharma Sci; 2012; 2():38-45. PubMed ID: 25755993
[TBL] [Abstract][Full Text] [Related]
4. The Impact of Magnesium-Aluminum-Layered Double Hydroxide-Based Polyvinyl Alcohol Coated on Magnetite on the Preparation of Core-Shell Nanoparticles as a Drug Delivery Agent.
Ebadi M; Buskaran K; Saifullah B; Fakurazi S; Hussein MZ
Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31374834
[TBL] [Abstract][Full Text] [Related]
5. Magnetic Fe3O4-graphene composites as targeted drug nanocarriers for pH-activated release.
Fan X; Jiao G; Zhao W; Jin P; Li X
Nanoscale; 2013 Feb; 5(3):1143-52. PubMed ID: 23288110
[TBL] [Abstract][Full Text] [Related]
6. Pectin and charge modified pectin hydrogel beads as a colon-targeted drug delivery carrier.
Jung J; Arnold RD; Wicker L
Colloids Surf B Biointerfaces; 2013 Apr; 104():116-21. PubMed ID: 23298595
[TBL] [Abstract][Full Text] [Related]
7. Eudragit-coated pectin microspheres of 5-fluorouracil for colon targeting.
Paharia A; Yadav AK; Rai G; Jain SK; Pancholi SS; Agrawal GP
AAPS PharmSciTech; 2007 Feb; 8(1):12. PubMed ID: 17408212
[TBL] [Abstract][Full Text] [Related]
8. Hyaluronidase enzyme core-5-fluorouracil-loaded chitosan-PEG-gelatin polymer nanocomposites as targeted and controlled drug delivery vehicles.
Rajan M; Raj V; Al-Arfaj AA; Murugan AM
Int J Pharm; 2013 Sep; 453(2):514-22. PubMed ID: 23796828
[TBL] [Abstract][Full Text] [Related]
9. Preparation and in vitro evaluation of 5-flourouracil loaded magnetite-zeolite nanocomposite (5-FU-MZNC) for cancer drug delivery applications.
Sağir T; Huysal M; Durmus Z; Kurt BZ; Senel M; Isık S
Biomed Pharmacother; 2016 Feb; 77():182-90. PubMed ID: 26796283
[TBL] [Abstract][Full Text] [Related]
10. Poly(3-hydroxybutyrate-CO-3-hydroxyvalerate) PHBHV biocompatible nanocarriers for 5-FU delivery targeting colorectal cancer.
Radu IC; Hudita A; Zaharia C; Galateanu B; Iovu H; Tanasa EV; Georgiana Nitu S; Ginghina O; Negrei C; Tsatsakis A; Velonia K; Shtilman M; Costache M
Drug Deliv; 2019 Dec; 26(1):318-327. PubMed ID: 30896267
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and characterization of thermo/pH-sensitive pectin-graft-poly(dimethylaminoethyl methacrylate) coated magnetic nanoparticles.
Işıklan N; Polat S
Int J Biol Macromol; 2020 Dec; 164():4499-4515. PubMed ID: 32898537
[TBL] [Abstract][Full Text] [Related]
12. Design and construction of polymerized-chitosan coated Fe3O4 magnetic nanoparticles and its application for hydrophobic drug delivery.
Ding Y; Shen SZ; Sun H; Sun K; Liu F; Qi Y; Yan J
Mater Sci Eng C Mater Biol Appl; 2015 Mar; 48():487-98. PubMed ID: 25579950
[TBL] [Abstract][Full Text] [Related]
13. Novel microbially triggered colon specific delivery system of 5-Fluorouracil: statistical optimization, in vitro, in vivo, cytotoxic and stability assessment.
Dev RK; Bali V; Pathak K
Int J Pharm; 2011 Jun; 411(1-2):142-51. PubMed ID: 21463667
[TBL] [Abstract][Full Text] [Related]
14. Potentiation of 5-fluorouracil encapsulated in zeolites as drug delivery systems for in vitro models of colorectal carcinoma.
Vilaça N; Amorim R; Machado AF; Parpot P; Pereira MF; Sardo M; Rocha J; Fonseca AM; Neves IC; Baltazar F
Colloids Surf B Biointerfaces; 2013 Dec; 112():237-44. PubMed ID: 23988779
[TBL] [Abstract][Full Text] [Related]
15. Preparation of new 5-fluorouracil-loaded zein nanoparticles for liver targeting.
Lai LF; Guo HX
Int J Pharm; 2011 Feb; 404(1-2):317-23. PubMed ID: 21094232
[TBL] [Abstract][Full Text] [Related]
16. Pectin/anhydrous dibasic calcium phosphate matrix tablets for in vitro controlled release of water-soluble drug.
Mamani PL; Ruiz-Caro R; Veiga MD
Int J Pharm; 2015 Oct; 494(1):235-43. PubMed ID: 26276258
[TBL] [Abstract][Full Text] [Related]
17. Galactosylated nanostructured lipid carriers for delivery of 5-FU to hepatocellular carcinoma.
Varshosaz J; Hassanzadeh F; Sadeghi H; Khadem M
J Liposome Res; 2012 Sep; 22(3):224-36. PubMed ID: 22385296
[TBL] [Abstract][Full Text] [Related]
18. Preparation of 5-fluorouracil-loaded nanoparticles and study of interaction with gastric cancer cells.
Fan YL; Fan BY; Li Q; Di HX; Meng XY; Ling N
Asian Pac J Cancer Prev; 2014; 15(18):7611-5. PubMed ID: 25292036
[TBL] [Abstract][Full Text] [Related]
19. Assessment of sequential combination of 5-fluorouracil-loaded-chitosan-nanoparticles and ALA-photodynamic therapy on HeLa cell line.
Benito-Miguel M; Blanco MD; Gómez C
Photodiagnosis Photodyn Ther; 2015 Sep; 12(3):466-75. PubMed ID: 25976508
[TBL] [Abstract][Full Text] [Related]
20. Targeting liver cancer via ASGP receptor using 5-FU-loaded surface-modified PLGA nanoparticles.
Dangi R; Hurkat P; Jain A; Shilpi S; Jain A; Gulbake A; Jain SK
J Microencapsul; 2014; 31(5):479-87. PubMed ID: 24697169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
